UB Paderborn / Katalog / Suche / in CDI

Mind the gap: Incidence of osteoporosis treatment after an osteoporotic fracture – results of the Austrian branch of the International Costs and Utilities Related to Osteoporotic Fractures Study (ICUROS)

Bone (New York, N.Y.), 2021-01, Vol.142, p.115071-115071, Article 115071

2021

Volltextzugriff (PDF)

The psoriasis area and severity index is an independent risk factor for cardiovascular events: A prospective register study

Journal of the European Academy of Dermatology and Venereology, 2023-09, Vol.37 (9), p.1841-1847

2023

Volltextzugriff (PDF)

Osteoporosis in the European Union: a compendium of country-specific reports

Archives of osteoporosis, 2013, Vol.8 (1-2), p.137-137, Article 137

2013

Volltextzugriff (PDF)

Quality of life for up to 18 months after low-energy hip, vertebral, and distal forearm fractures—results from the ICUROS

Osteoporosis international, 2018-03, Vol.29 (3), p.557-566

2018

Volltextzugriff (PDF)

Osteoporosis in the European Union: medical management, epidemiology and economic burden: A report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA)

Archives of osteoporosis, 2013, Vol.8 (1-2), p.136-136, Article 136

2013

Volltextzugriff (PDF)

Real‐world comparative effectiveness of adalimumab, etanercept and methotrexate: a Swedish register analysis

Journal of the European Academy of Dermatology and Venereology, 2020-03, Vol.34 (3), p.525-532

2020

Volltextzugriff (PDF)

Cost-effectiveness of pharmacological fracture prevention for osteoporosis as prescribed in clinical practice in France, Germany, Italy, Spain, and the United Kingdom

Osteoporosis international, 2019-09, Vol.30 (9), p.1745-1754

2019

Volltextzugriff (PDF)

Balloon kyphoplasty compared to vertebroplasty and nonsurgical management in patients hospitalised with acute osteoporotic vertebral compression fracture: a UK cost-effectiveness analysis

Osteoporosis international, 2013, Vol.24 (1), p.355-367

2013

Volltextzugriff (PDF)

Circulating microRNAs in extracellular vesicles as potential biomarkers for psoriatic arthritis in patients with psoriasis

Journal of the European Academy of Dermatology and Venereology, 2020-06, Vol.34 (6), p.1248-1256

2020

Volltextzugriff (PDF)

Epidemiology and economic burden of osteoporosis in Switzerland

Archives of osteoporosis, 2014, Vol.9 (1), p.187-187, Article 187

2014

Volltextzugriff (PDF)

Health-related quality of life during the first year after a hip fracture: results of the Mexican arm of the International Cost and Utility Related to Osteoporotic Fractures Study (MexICUROS)

Osteoporosis international, 2018-05, Vol.29 (5), p.1147-1154

2018

Volltextzugriff (PDF)

A micro-costing analysis of post-fracture care pathways: results from the International Costs and Utilities Related to Osteoporotic Fractures Study (ICUROS)

Osteoporosis international, 2022-09, Vol.33 (9), p.1895-1907

2022

Volltextzugriff (PDF)

The International Costs and Utilities Related to Osteoporotic Fractures Study (ICUROS)—quality of life during the first 4 months after fracture

Osteoporosis international, 2013-03, Vol.24 (3), p.811-823

2013

Volltextzugriff (PDF)

Clinical course of multiple sclerosis and labour‐force absenteeism: a longitudinal population‐based study

European journal of neurology, 2019-04, Vol.26 (4), p.603-609

2019

Volltextzugriff (PDF)

Microscopic Colitis and Risk of Incident Psoriasis: A Nationwide Population-Based Matched Cohort Study

Clinical epidemiology, 2024-01, Vol.16, p.213-225

2024

Volltextzugriff (PDF)

Epidemiology of proximal humeral fractures in Austria between 1989 and 2008

Osteoporosis international, 2013-09, Vol.24 (9), p.2413-2421

2013

Volltextzugriff (PDF)

Comparative cost-effectiveness of bazedoxifene and raloxifene in the treatment of postmenopausal osteoporosis in Europe, using the FRAX algorithm

Osteoporosis international, 2014, Vol.25 (1), p.325-337

2014

Volltextzugriff (PDF)

SAT0575 First and Second Line Treatment Persistence among Patients with Immune-Mediated Rheumatoid Disease Treated with Subcutaneous TNF-alpha Inhibitors

Annals of the rheumatic diseases, 2016-06, Vol.75 (Suppl 2), p.877-877

2016

Volltextzugriff (PDF)

Epidemiology of hip fractures in Austria: evidence for a change in the secular trend

Osteoporosis international, 2011-02, Vol.22 (2), p.685-692

2011

Volltextzugriff (PDF)

Quality of life, resource use, and costs related to hip fracture in Estonia

Osteoporosis international, 2016-08, Vol.27 (8), p.2555-2566

2016

Volltextzugriff (PDF)

Real-World Patient Experience of Switching Biologic Treatment in Inflammatory Arthritis and Ulcerative Colitis - A Systematic Literature Review

Patient preference and adherence, 2020-01, Vol.14, p.309-320

2020

Volltextzugriff (PDF)

Persistence with golimumab in immune-mediated rheumatic diseases: a systematic review of real-world evidence in rheumatoid arthritis, axial spondyloarthritis, and psoriatic arthritis

Patient preference and adherence, 2017-01, Vol.11, p.719-729

2017

Volltextzugriff (PDF)

Treatment patterns with topicals, traditional systemics and biologics in psoriasis - a Swedish database analysis

Journal of the European Academy of Dermatology and Venereology, 2015-02, Vol.29 (2), p.215-223

2015

Volltextzugriff (PDF)

Persistence and costs with subcutaneous TNF-alpha inhibitors in immune-mediated rheumatic disease stratified by treatment line

Patient preference and adherence, 2017-01, Vol.11, p.95-106

2017

Volltextzugriff (PDF)

Epidemiology of distal forearm fractures in Austria between 1989 and 2010

Osteoporosis international, 2014-09, Vol.25 (9), p.2297-2306

2014

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Mind the gap: Incidence of osteoporosis treatment after an osteoporotic fracture – results of the Austrian branch of the International Costs and Utilities Related to Osteoporotic Fractures Study (ICUROS)

The psoriasis area and severity index is an independent risk factor for cardiovascular events: A prospective register study

Osteoporosis in the European Union: a compendium of country-specific reports

Quality of life for up to 18 months after low-energy hip, vertebral, and distal forearm fractures—results from the ICUROS

Osteoporosis in the European Union: medical management, epidemiology and economic burden: A report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA)

Real‐world comparative effectiveness of adalimumab, etanercept and methotrexate: a Swedish register analysis

Cost-effectiveness of pharmacological fracture prevention for osteoporosis as prescribed in clinical practice in France, Germany, Italy, Spain, and the United Kingdom

Balloon kyphoplasty compared to vertebroplasty and nonsurgical management in patients hospitalised with acute osteoporotic vertebral compression fracture: a UK cost-effectiveness analysis

Circulating microRNAs in extracellular vesicles as potential biomarkers for psoriatic arthritis in patients with psoriasis

Epidemiology and economic burden of osteoporosis in Switzerland

Health-related quality of life during the first year after a hip fracture: results of the Mexican arm of the International Cost and Utility Related to Osteoporotic Fractures Study (MexICUROS)

A micro-costing analysis of post-fracture care pathways: results from the International Costs and Utilities Related to Osteoporotic Fractures Study (ICUROS)

The International Costs and Utilities Related to Osteoporotic Fractures Study (ICUROS)—quality of life during the first 4 months after fracture

Clinical course of multiple sclerosis and labour‐force absenteeism: a longitudinal population‐based study

Microscopic Colitis and Risk of Incident Psoriasis: A Nationwide Population-Based Matched Cohort Study

Epidemiology of proximal humeral fractures in Austria between 1989 and 2008

Comparative cost-effectiveness of bazedoxifene and raloxifene in the treatment of postmenopausal osteoporosis in Europe, using the FRAX algorithm

SAT0575 First and Second Line Treatment Persistence among Patients with Immune-Mediated Rheumatoid Disease Treated with Subcutaneous TNF-alpha Inhibitors

Epidemiology of hip fractures in Austria: evidence for a change in the secular trend

Quality of life, resource use, and costs related to hip fracture in Estonia

Real-World Patient Experience of Switching Biologic Treatment in Inflammatory Arthritis and Ulcerative Colitis - A Systematic Literature Review

Persistence with golimumab in immune-mediated rheumatic diseases: a systematic review of real-world evidence in rheumatoid arthritis, axial spondyloarthritis, and psoriatic arthritis

Treatment patterns with topicals, traditional systemics and biologics in psoriasis - a Swedish database analysis

Persistence and costs with subcutaneous TNF-alpha inhibitors in immune-mediated rheumatic disease stratified by treatment line

Epidemiology of distal forearm fractures in Austria between 1989 and 2010

Suchergebnisse filtern